Moolec Science SA Schedules Shareholder Meetings

Ticker: MLECW · Form: 6-K · Filed: Dec 30, 2024 · CIK: 1937737

Sentiment: neutral

Topics: shareholder-meeting, corporate-governance, filing-update

Related Tickers: MLEC

TL;DR

MLEC holding shareholder meetings Dec 27, info incorporated into F-3/S-8 filings.

AI Summary

Moolec Science SA announced its 2024 Annual Shareholders' Meeting and Extraordinary General Meeting of Shareholders will be held on December 27, 2024. The information from this Form 6-K is incorporated into the company's existing registration statements on Form F-3 (Registration No. 333-283113) and Form S-8 (Registration No. 333-282263).

Why It Matters

The company is holding key shareholder meetings to discuss corporate matters, which is a standard governance process for public companies.

Risk Assessment

Risk Level: low — This filing is a routine announcement of shareholder meetings and incorporation of information into existing filings, with no new financial or operational disclosures that would significantly alter risk.

Key Players & Entities

FAQ

What is the purpose of this Form 6-K filing?

This Form 6-K announces that Moolec Science SA will hold its 2024 Annual Shareholders' Meeting and Extraordinary General Meeting of Shareholders.

When are the shareholder meetings scheduled to take place?

The shareholder meetings are scheduled for December 27, 2024.

Which registration statements does the information in this filing get incorporated into?

The information is incorporated by reference into the Company's registration statements on Form F-3 (Registration No. 333-283113) and Form S-8 (Registration No. 333-282263).

What is Moolec Science SA's stock ticker and exchange?

Moolec Science SA's stock ticker is MLEC, and it is listed on NASDAQ.

What is the company's principal executive office address?

The company's principal executive offices are located at 17, Boulevard F. W. Raiffeisen, L-2411 Luxembourg, Grand Duchy of Luxembourg.

Filing Stats: 1,253 words · 5 min read · ~4 pages · Grade level 12.5 · Accepted 2024-12-27 18:30:17

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. MOOLEC SCIENCE SA (Registrant) Dated: December 27, 2024 By: /s/ Gastón Paladini Name: Gastón Paladini Title: Chief Executive Officer 3

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing